- Talanx has reported a preliminary net income of EU572 million for Q1 2024
- The company still sees its annual net income exceeding EU1.7 billion
- Despite the positive outcome in the first quarter, the forecast for the full-year is maintained
- There is increased confidence that the targeted group result can significantly exceed more than EUR 1.7 billion
- This earnings target operates under assumptions including no large losses exceeding the large loss budget
- The forecast also requires the capital markets to avoid major upheavals
- The earnings target does not account for material currency fluctuations
- Talanx currently holds two buy ratings, six hold ratings, and two sell ratings
A look at Talanx Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts using Smartkarma Smart Scores have given Talanx a positive overall outlook based on key factors. With above-average scores in Dividend, Growth, and Momentum, Talanx is positioned for long-term success. The company’s strong dividend and growth potential indicate stability and future profitability. Additionally, its momentum score suggests positive market sentiment and potential for continued growth. This bodes well for investors seeking a reliable and growing investment option.
Talanx, a holding company offering insurance and financial services globally, demonstrates resilience in the face of economic challenges, as reflected in its above-average Resilience score. This resilience, coupled with strong performance in key areas, positions Talanx as an attractive long-term investment opportunity. Investors looking for a company with a solid dividend, growth prospects, and market momentum may find Talanx to be a promising choice in the insurance sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
